CD6-targeted antibody-drug conjugate as a new therapeutic agent for T cell lymphoma. Parameswaran N, Luo L, Zhang L, Chen J, et al. Leukemia 2023 Aug 12. doi: 10.1038/s41375-023-01997.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Parameswaran N, Luo L, Zhang L, Chen J, et al. CD6-targeted antibody-drug conjugate as a new therapeutic agent for T cell lymphoma. Leukemia 2023 Aug 12. doi: 10.1038/s41375-023-01997.
PMID: 37573404